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Abstract
Described is the construction of the N-methylwelwitindolinone C core via an efficient strategy that
employs a sequential rhodium carbenoid-mediated O–H insertion, Claisen rearrangement and
transannular [3+2] nitrone cycloaddition.
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1. Introduction
Since their isolation in 1994 from the cyanobacteria Hapalosiphon welwitschii and Westiella
intricate, the welwitindolinone alkaloids have received significant attention from the
synthetic community.1–18 Of biological relevance, it was found that N-
methylwelwitindolinone C isothiocyanate (1) was responsible for the P-glycoprotein-
mediated MDR-reversing and larvacidal activities associated with the algae extracts.19,20
Intrigued by its structural complexity and promising biological activity, we initiated a
program for the total synthesis of 1. Our initial attempt (Path A, Scheme 1), reported in
1999, highlighted the utility of Montmorillonite K-10 clay in a rhodium catalyzed C–H aryl
insertion reaction that provided access to key α-diazo ketone 4. Subsequent O–H insertion
chemistry produced enol ether 3, which was further elaborated to the welwitindolinone core
(2) in 4 steps. Unfortunately, numerous attempts to install the bridgehead nitrogen failed;21
thus an alternate strategy was devised. Herein we report the details of this approach (Path B,
Scheme 1) which calls for the preparation of intermediate isoxazolidine 7 via a nitrone-
mediated transannular [3+2] dipolar cycloaddition of olefin 6.22,23–26 Taking maximum
advantage of our prior efforts, olefin 6 was seen as arising from the previously prepared
diazoketone 4 by employing a two-step sequence involving rhodium-catalyzed O–H
insertion/ring-opening to deliver enol ether 5 followed by Claisen rearrangement.4,27,28
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2. Results and discussions
As previously reported,4 diazoketone 4 was efficiently accessed from isatin (8) as outlined
in Scheme 2. In the event 8 was converted to carboxylic acid 11 by a three-step sequence
involving Wittig olefination (8 → 9), phosphonium ylide-induced cyclopropanation–N-
alkylation (9 → 10), and hydrolysis of the resultant ethyl ester (10 → 11). Subsequent acid
chloride formation and treatment with trimethylsilyl diazomethane provided the desired α-
diazo ketone 12. After an extensive catalyst screen, it was found that Rh2(TFA)4 in the
presence of Montmorillonite K-10 clay optimally promoted the aryl C–H insertion reaction
to provide tetracycle 13. Benzylic oxidation of ketone 13 and regioselective diazotization
afforded diazoketone 4.
With ready access to α-diazoketone (4) and taking inspiration from early reports by Funk,22
we turned toward the transannular nitrone cycloaddition (Scheme 3). In initial studies we
targeted model substrate 15 and thus began with the Rh(II)-promoted coupling of 4 with
allyl alcohol. In the event, sequential O–H insertion/cyclopropane ring-opening furnished
known enol ether 14.4 Subsequent Claisen rearrangement under thermal conditions provided
the desired diketone (15) as a an initial 1:1 mixture of diastereomers that underwent
equilibration to the illustrated single diastereomer upon silica gel chromatography.
Having installed the pendant olefin, we were poised for the proposed cycloaddition and were
delighted to find that exposure of 15 to N-methylhydroxylamine and pyridine in methanol at
reflux regioselectively furnishes a nitrone (observed but not isolated) which, in turn,
undergoes [3+2] cyloaddition to produce 16 in 81% yield. Although this single-step
procedure established the viability of the transannular cycloaddition for installing the
requisite bridgehead nitrogen, issues of ring size, cleavage of the N–O bond, and nitrogen
deprotection remained. Regarding the latter, the use of N-benzyl hydroxylamine (Scheme 4)
is representative of several variations which were explored and found to either resist
cycloaddition or give large amounts of oxazole side-products via dehydration of the
intermediate nitrone (i.e., 18).29,30 Eventually a more satisfactory solution that allowed
advancement of the N-methylhydroxylamine adducts was implemented (vide infra).
23,24,31,25,26
Turning to the issue of ring size, we targeted intermediate 21, a compound that was both
accessible via the developed O–H insertion/ring-opening/Claisen rearrangement cascade and
poised for an olefin transposition that would set the stage for cycloaddition to the requisite
six-membered ring of 1 (Scheme 5). Implementation of this plan began with the
combination of diazoketone 4 and alcohol 19 in the presence of Rh2(OAc)4.32 The derived
enol ether 20 was subjected to thermally-induced Claisen rearrangement conditions to
provide acetate 21 which was isolated as a single isomer after purification.33 Palladium-
catalyzed allylic transposition of 21 to the contra-thermodynamic terminal alkene 22 was
followed by the key [3+2] dipolar cycloaddition.34,35 To our delight, exposure of diketone
22 to N-methylhydroxylamine in EtOH at reflux gave isoxazolidine 23 as a complex mixture
of diastereomers; thus, completing assembly of the welwitindolinone core.36
Although success in accessing 23 further established the O–H insertion/Claisen
rearrangement sequence as quite general and illustrated the feasibility of accessing both the
bridghead nitrogen and six-membered ring, inefficiencies associated with the olefin
transposition led us to briefly explore alternatives. To this end, it was envisioned that
replacing 19 with alcohol 24 would allow us to avoid the olefin transposition and provide a
more functionalized isoxazolidine (Scheme 6).37–39 As illustrated, exposure of diazoketone
4 to alcohol 24 in the presence of Rh2(OAc)4 produced enol ether 25, which was converted
to diketone 26 upon heating. However, subsequent treatment of diketone 26 to our
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established cycloaddition conditions failed to provide desired cycloadduct 27. Instead,
cyclization of the intermediate nitrone (not shown) onto the 1,1-disubstituted olefin
converted diketone 26 exclusively to adduct 28, the structure of which was confirmed by X-
ray crystallography.40 Attempts to modify the chemoselectivity of the cycloaddition by
removal of the trimethylsilyl group or by olefin functionalization were unsuccessful.
Although the selectivity observed in the cycloaddition of 26 was disappointing we were
encouraged by our ability to stereoselectively forge the fully-substituted quaternary carbon
adjacent to the bridgehead nitrogen and thus began pursuing an alternative wherein the
requisite [4.3.1] bicyclic backbone and C12 quaternary center would be produced in a single
step (Scheme 7). The designed cyclization substrate in this scenario (33) was prepared in a
sequence that began with cross metathesis of diketone 15 and silyl ether 29 followed by silyl
deprotection.41,42 The derived alcohol (30) was isolated as an inconsequential mixture of E/
Z diastereomers (2:1, respectively). Selenenylation of 30 via the method of Grieco [o-
(NO2)C6H4-SeCN and P(n-Bu)3] furnished selenide 31 which,43–45 upon oxidation with
DMDO provided the corresponding epoxy selenoxide. As expected the latter was unstable
and upon work-up underwent clean elimination to deliver vinyl epoxide 32 in good yield.
46,47
Having accessed 32, attention was turned to opening the epoxide and delivering the
cycloaddition substrate (33). After considerable fruitless experimentation with several Lewis
acids we eventually explored a palladium-catalyzed isomerization approach pioneered by
Noyori48 and modified more recently by Radinov.49 Under the latter conditions, opening of
vinyl epoxide 32 in the presence of a fluorinated alcohol proceeded to furnish hemiacetals
33α and 33β as an inseparable mixture of diastereomers. Although the intermediacy of the
hemiacetals was expected, the effect of the altered electronics on the subsequent
cycloadditon was uncertain (cf., 26 and 33). Unfortunately, exposure of 33α and 33β to N-
methylhydroxylamine under forcing conditions did not produce any of the desired
cycloadduct 34.
In addition to our efforts with the more advanced cycloaddition substrates illustrated in
Schemes 6 and 7, we had continued exploring cycloadduct 23 as a potential intermediate
(Scheme 8). In these more fruitful studies, recent results from our synthetic approach to
welwitindolinone A (35) were most influential and we targeted allylic alcohol 38 as an
eventual substrate for a chloronium-ion induced semi-pinacol rearrangement that was
envisioned as giving rise to the desired quaternary center and requisite neopentyl chlorine.
11,13,50
As illustrated in Scheme 9, isoxazolidine 23 was advanced by first rearranging to the
corresponding aminal (39).26,51 Subsequent treatment of 39 with hydroxylamine
hydrochloride produced amino-alcohol 40 in 95% yield. To set the stage for eventual
introduction of the bridgehead isonitrile, 40 was bis-fomylated.52,53 Selective deformylation
of the derived formate produced alcohol 41 which, in a three-step process involving
oxidation with Dess–Martin periodinane (DMP),54 base-induced elimination to the enal, and
addition of methyl magnesium bromide, was converted to secondary alcohol 42 as an
inconsequential mixture of diastereomers. In practice, the instability to silica gel of the
intermediates produced in this three-step sequence required that it be performed without
purification. Finally, oxidation of alcohol 42 to enone 43, followed by addition of methyl
magnesium bromide, provided desired tertiary allylic alcohol 38, albeit in low yield.
Despite its poor overall yield, the unoptimized synthetic sequence leading to 38 provided
sufficient material to explore the proposed halonium ion induced semi-pinacol
rearrangement. In the event, exposure of 38 to CeCl3 7H2O and NaOCl was found to
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produce 44. Extensive NMR analysis indicated that chloronium ion activation resulting in
rearrangement had occurred from what appeared to be the desired and sterically more
demanding face. However this transformation was accompanied by over-chlorination. Given
our success in applying this type of semi-pinacol in the welwitindolinone A synthesis
(Scheme 8) we were both surprised and dissappointed.11,13 In recent efforts to overcome
this problem, preliminary studies wherein the stoichiometry of the oxidant is limited have
revealed that in substrate 38 the aromatic system reacts first. Thus, as is often the case with
synthetic endeavors, the absence of a simple solution has inspired further efforts and the
completion of 1 continues to challenge our resolve.
3. Conclusion
In summary, we have developed a novel approach toward the synthesis of N-
methylwelwitindolinone C isothiocyanate (1) that employs a sequential O–H insertion/
Claisen rearrangement followed by a transannular [3+2] nitrone cycloaddition to efficiently
deliver a heavily functionalized carbocyclic welwitindolinone core (23). Further
advancement of 23 via a chloronium-ion induced semi-pinacol rearrangement allows
installation of the requisite quaternary center; however, over functionalization in this process
has to-date thwarted efforts to complete the synthesis. The exploration of alternative
strategies for accessing 1 as well as optimization studies on reactions leading to 23 are
currently underway.
4. Experimental
4.1. General
Unless otherwise stated, reactions were magnetically stirred in flame-dried glassware under
an atmosphere of nitrogen. Triethylamine (Et3N) and methanol were dried over calcium
hydride. Benzene, tetrahydrofuran, dichloromethane, toluene, and diethyl ether were dried
using a solvent purification system manufactured by SG Water U.S.A., LLC. All other
commercially available reagents were used as received.
Unless otherwise stated, all reactions were monitored by thin-layer chromatography (TLC)
using Silicycle glass-backed extra hard layer, 60 Å plates (indicator F-254, 250 μm).
Column or flash chromatography was performed with the indicated solvents using Silicycle
SiliaFlash® P60 (230–400 mesh) silica gel as the stationary phase. Chromatography was
conducted in accordance with the guidelines reported by Still et al.55 All melting points
were obtained on a Gallenkamp capillary melting point apparatus and are uncorrected.
Infrared spectra were obtained using a Midac M1200 FTIR or a Nicolet Avatar 320
FTIR. 1H and 13C NMR spectra were recorded on a Bruker AM-500, Bruker Avance
DPX-500, Bruker Avance DPX-400, or Varian Inova 400 spectrometer. Chemical shifts (δ)
are reported in parts per million (ppm) relative to internal residual solvent peaks from
indicated deuterated solvents. High-resolution mass spectra were performed at the
University of Illinois Mass Spectrometry Center or by Donald L. Dick of Colorado State
University. Single-crystal X-ray analyses were performed by Susan DeGala of Yale
University.
4.1.1. Diketone 15—To a solution of diazo ketone 4 (630 mg, 2.36 mmol, 1.0 equiv) and
allyl alcohol (161 μL, 2.36 mmol, 1.0 equiv) in CH2Cl2 (24 mL) was added Rh2(OAc)4
(10.4 mg, 0.024 mmol, 0.01 equiv). Gas evolution was observed and the reaction turned
dark brown. After stirring at rt for 20 minutes, the mixture was concentrated to afford a dark
brown oil which was subsequently dissolved in xylenes (35 mL) and heated at reflux for 1
hour. After cooling to room temperature, the reaction was concentrated and purified by silica
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gel column chromatography (30% hexane/EtOAc) to afford diketone 15 as yellow crystals
(596 mg, 85% yield). m.p. 196–197 °C; FTIR (thin film/NaCl) 3079, 2895, 1706, 1597,
1467, 1408, 1368, 1337, 1295, 1269, 1187, 1161, 1140, 1019 cm−1; 1H NMR (500 MHz,
CDCl3) δ 7.68 (d, J = 7.6 Hz, 1H), 7.50 (t, J = 8.0 Hz, 1H), 7.12 (d, J = 7.6 Hz, 1H), 5.59
(dddd, J = 6.7, 6.7, 10.3, 17.0 Hz, 1H), 5.02–4.98 (m, 2H), 3.36 (s, 1H), 3.25 (s, 3H), 2.93
(dd, J = 2.4, 11.6 Hz, 1H), 2.74 (ddd, J = 6.9, 12.2, 13.2 Hz, 1H), 2.18 (ddd, J = 1.0, 6.4,
14.0 Hz, 1H), 1.50 (s, 3H), 0.93 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 204.7, 192.5,
174.3, 145.1, 134.8, 129.6, 129.1, 128.6, 120.7, 117.6, 113.3, 57.2, 53.0, 38.4, 29.9, 26.4,
22.7, 20.9; HRMS (EI) m/z 297.1364 [calc’d for C18H19NO3 (M+) 297.1365].
4.1.2. Isoxazolidine 16—To a solution of diketone 15 (386 mg, 1.30 mmol 1.0 equiv) in
MeOH (15 mL) was added N-methylhydroxylamine hydrochloride (543 mg, 6.50 mmol, 5.0
equiv) followed by pyridine (736 μL, 9.10 mmol, 7.0 equiv). The reaction mixture was
heated at reflux for 15 hours and was concentrated after cooling to room temperature. The
residual pyridine was removed in vacuo and the crude white solid was redissolved in EtOH
(18 mL) and imidazole hydrochloride was added (272 mg, 2.60 mmol, 2.0 equiv). The
mixture was heated at reflux for an additional 14 hours. After cooling to room temperature,
the reaction was concentrated and purified by silica gel column chromatography (30%
hexane/EtOAc) to furnish cycloadduct 16 as white crystals (342 mg, 81% yield). m.p. 206–
207 °C; FTIR (thin film/NaCl) 2964, 2928, 2872, 1709, 1593, 1588, 1468, 1368, 1334,
1300, 1210, 1169, 1146, 1115, 1077, 1008 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.33 (t, J =
8.2 Hz, 1H), 7.02 (d, J = 8.0 Hz, 1H), 6.72 (d, J = 8.1 Hz, 1H), 3.99 (dd, J = 6.5, 8.7 Hz,
1H), 3.77 (d, J = 8.8 Hz, 1H), 3.49 (s, 1H), 3.28 (m, 1H), 3.23 (s, 3H), 3.19 (s, 3H), 2.61 (dd,
J = 9.7, 14.1 Hz, 1H), 2.38 (d, J = 8.3 Hz, 1H), 1.97 (ddd, J = 8.7, 8.7, 14.1 Hz, 1H), 1.58 (s,
3H), 0.77 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 212.8, 175.0, 144.5, 135.1, 128.9, 123.6,
117.3, 106.8, 76.4, 73.1, 65.3, 52.4, 51.7, 42.2, 39.7, 28.8, 26.3, 25.1, 21.4; HRMS (EI) m/z
326.1627 [calc’d for C19H22N2O3 (M+) 326.1630].
4.1.3. Isoxazolidine 17 and Oxazole 18—To a solution of diketone 15 (96 mg, 0.32
mmol, 1.0 equiv.) in MeOH (5 mL) was added N-benzylhydroxylamine hydrochloride (258
mg, 1.62 mmol, 5.0 equiv.) followed by pyridine (131 μL, 1.62 mmol, 5.0 equiv.). The
reaction mixture was heated at reflux for 15 hours and was concentrated after cooling to
room temperature. The residual pyridine was removed in vacuo and the crude white solid
was redissolved in EtOH (8 mL) and imidazole hydrochloride was added (34 mg, 0.32
mmol, 1.0 equiv.). The mixture was heated at reflux for an additional 18 hours. After
cooling to room temperature, the reaction was concentrated and purified by silica gel
column chromatography (30% hexane/EtOAc) to afford oxazole 18 as a white solid (50 mg,
40% yield) and cycloadduct 17 as a white solid (62 mg 48% yield). 17: m.p. >243 °C; FTIR
(thin film/NaCl) 2969, 2924, 2873, 1739, 1697, 1608, 1592, 1470, 1368, 1341, 1304, 1149,
1080, 1012, 986, 910, 774, 728, 699 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.56 (d, J = 7.7
Hz, 2H), 7.40 (t, J = 7.6 Hz, 2H), 7.30 (m, 2H), 7.06 (d, J = 7.9 Hz, 1H), 6.74 (d, J = 7.6 Hz,
1H), 4.89 (d, J = 16.4 Hz, 1H), 4.52 (d, J = 16.5 Hz, 1H), 4.02 (dd, J = 6.8, 8.6 Hz, 1H),
3.78 (d, J = 8.6 Hz, 1H), 3.55 (s, 1H), 3.32 (dd, J = 9.0, 15.6 Hz, 1H), 3.21 (s, 3H), 2.66 (dd,
J = 10.0, 14.4 Hz, 1H), 2.45 (d, J = 8.5 Hz, 1H), 2.03 (ddd, J = 8.6, 8.6, 14.4 Hz, 1H), 1.62
(s, 3H), 0.82 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 213.4, 175.1, 144.6, 139.4, 135.0,
129.1, 128.4, 127.5, 126.9, 123.7, 117.4, 106.9, 76.6, 73.6, 65.1, 55.3, 51.9, 51.7, 42.2, 28.9,
26.3, 25.1, 21.5; HRMS (FAB) m/z 403.2022 [calc’d for C25H27N2O3 (M+1) 403.2022]. 18:
m.p. 156–157 °C; FTIR (thin film/NaCl) 2930, 1707, 1618, 1600, 1464, 1372, 1337, 1299,
1083, 915, 784 cm−1; 1H NMR (500 MHz, CDCl3) δ 8.09 (m, J = 1.7, 8.0 Hz, 2H), 7.91 (d,
J = 7.5 Hz, 1H), 7.51-7.47 (m, 3H), 7.41 (t, J = 7.9 Hz, 1H), 6.78 (d, J = 7.5 Hz, 1H), 5.91
(dddd, J = 6.3, 8.4, 10.3, 16.8 Hz, 1H), 5.10-5.03 (m, 2H), 3.74 (s, 1H), 3.25 (s, 3H), 3.00
(dd, J = 4.2, 7.4 Hz, 1H), 2.90 (m, 1H), 2.49 (ddd, J = 7.4, 7.6, 14.7 Hz, 1H), 1.68 (s, 3H),
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0.77 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 175.2, 160.0, 150.6, 143.8, 136.3, 133.5,
130.2, 128.8, 128.2, 128.1, 127.5, 126.3, 122.7, 119.1, 116.9, 106.6, 50.4, 50.1, 38.2, 34.2,
26.4, 25.9, 24.9; HRMS (EI) m/z 384.1839 [calc’d for C25H24N2O2 (M+) 384.1838].
4.1.4. Acetate 21—To a solution of diazo ketone 4 (6.00 g, 22.4 mmol, 1.0 equiv.) and
allylic alcohol 19 (3.50 g, 26.9 mmol, 1.2 equiv.) in CH2Cl2 (224 mL) at room temperature
was added Rh2(OAc)4 (250 mg, 0.56 mmol, 0.02 equiv.). As soon as gas evolution ceased
(ca. 1 minute), Et3N (15.6 mL, 112 mmol, 5.0 equiv.) was quickly added at once via syringe.
The mixture was concentrated to afford a dark purple oil which was subsequently dissolved
in xylenes (224 mL) and heated at reflux for 45 minutes. After cooling to room temperature,
the reaction was concentrated and purified by silica gel column chromatography (20%
acetone/hexanes) to afford diketone 21 as a yellow solid (5.36 g, 65% yield). m.p. 170–172
°C; FTIR (thin film/NaCl) 2971, 2939, 2885, 1716, 1603, 1472, 1372, 1339, 1300, 1268,
1233 cm−1; 1H NMR (500 MHz, Acetone-d6) δ 7.63 (d, J = 7.9 Hz, 1H), 7.48 (t, J = 7.9 Hz,
1H), 7.10 (d, J = 7.7 Hz, 1H), 5.55-5.46 (m, 2H), 4.40 (dd, J = 3.6, 27.0 Hz, 1H), 4.37 (dd, J
= 4.7, 27.0 Hz, 1H), 3.30 (s, 1H), 3.22 (s, 3H), 2.89 (dd, J = 2.3, 11.5 Hz, 1H), 2.72 (m, 1H),
2.17-2.13 (m, 1H), 2.00 (s, 3H), 1.45 (s, 3H), 0.89 (s, 3H); 13C NMR (125 MHz, CDCl3) δ
205.2, 193.3, 174.9, 170.6, 146.5, 132.6, 130.4, 130.0, 129.8, 127.9, 120.6, 114.4, 64.7,
57.9, 53.6, 263–38.9, 29.1, 26.5, 22.9, 21.1, 20.7; HRMS (EI) m/z 369.1571 [calc’d for
C21H23NO5 (M+) 369.1576].
4.1.5. Acetates 22—To a solution of a acetate 21 (4.25 g, 11.5 mmol, 1.0 equiv) in THF
(115 mL) was added PdCl2(MeCN)2 (119 mg, 0.46 mmol, 0.04 equiv) and the reaction was
warmed to 50 °C. After stirring for 2 hours, the reaction was cooled to room temperature,
concentrated, adsorbed onto SiO2 and subjected to flash chromatography (30% EtOAc/
hexanes) to provide a 1:1.4 ratio of diastereomers of olefins 22a and 22b (1.20 g, 28% yield,
96% yield based on recovered starting material) and recovered acetate 21 (3.00 g, 71%
yield). 22a: Although the mixture will be carried on in the next step, separation of the minor
diastereomer (22a) can be affected via recrystallization from EtOAc/hexanes: m.p. 194–195
°C; FTIR (thin film/NaCl) 2974, 2938, 1716, 1603, 1473, 1372, 1339, 1299, 1271, 1234,
1018 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.65 (d, J = 8.0 Hz, 1H), 7.51 (dd, J = 7.9 Hz,
1H), 7.13 (d, J = 7.8 Hz, 1H), 5.66 (ddd, J = 6.3, 10.6, 17.1 Hz, 1H), 5.19-5.14 (m, 2H), 5.04
(ddd, J = 4.8, 4.8, 9.4 Hz, 1H), 3.34 (s, 1H), 3.25 (s, 3H), 2.83 (d, J = 10.6 Hz, 1H), 2.46
(ddd, J = 10.0, 10.0, 14.2 Hz, 1H), 2.06 (s, 3H), 1.76 (dd, J = 4.1, 14.2 Hz, 1H), 1.47 (s, 3H),
0.89 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 204.0, 192.4, 174.3, 170.5, 145.0, 135.4,
129.7, 129.1, 128.3, 120.6, 117.6, 113.3, 74.1, 53.9, 52.7, 38.5, 30.9, 26.4, 22.5, 21.2, 20.5;
HRMS (EI) m/z 369.1586 [calc’d for C21H23NO5 (M+) 369.1576]. 22b: m.p. 97–99 °C
(wax); FTIR (thin film/NaCl) 2972, 2939, 1717, 1603, 1472, 1373, 1339, 1299, 1271, 1233,
1022 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.69 (d, J = 8.0 Hz, 1H), 7.52 (t, J = 7.9 Hz, 1H),
7.12 (d, J = 7.8 Hz, 1H), 5.58 (m, 1H), 5.29 (m, 1H), 5.12-5.09 (m, 2H), 3.35 (s, 1H), 3.25
(s, 3H), 2.93 (d, J = 11.1 Hz, 1H), 2.55 (ddd, J = 5.7, 11.2, 14.1 Hz, 1H), 2.07 (s, 3H), 1.67
(dd, J = 4.0, 14.1 Hz, 1H), 1.45 (s, 3H), 0.86 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 204.2,
192.0, 174.4, 170.0, 144.9, 134.9, 129.6, 129.3, 128.2, 120.5, 117.3, 113.2, 71.9, 52.7, 51.6,
38.2, 30.0, 26.4, 22.4, 20.8, 20.5; HRMS (EI) m/z 369.1575 [calc’d for C21H23NO5 (M+)
369.1576].
4.1.6. Isoxazolidines 23—N-Methylhydroxylamine hydrochloride (3.35 g, 40.1 mmol,
10.0 equiv.) was dissolved in EtOH (200 mL) via gentle heating with a heat gun. NaOMe
(3.38 g, 40.5 mmol, 10.1 equiv.) was added, which resulted in immediate salt formation. The
mixture was stirred for 2 hours and was then filtered into a round bottom flask containing
acetates 22 (1.48 g, 4.01 mmol, 1.0 equiv.). The reaction was heated at reflux for 18.5 hours,
which resulted in a complex mixture of products as visualized by NMR. After cooling to
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room temperature, the reaction was concentrated in vacuo, adsorbed onto SiO2, and
subjected to flash chromatography (30–75% EtOAc/hexanes). Three diastereomers were
isolated and characterized as follows: 23a and 23b: (865 mg, 54% yield) FTIR (thin film/
NaCl) 2968, 2933, 2878, 1744, 1708, 1603, 1592, 1464, 1368, 1339, 1300, 1235, 1143,
1118, 1037 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.58 (d, J = 8.0 Hz, 1H), 7.41 (t, J = 8.0
Hz, 1H), 7.35-7.26 (m, 2H), 6.79 (d, J = 8.0 Hz, 1H), 6.75 (d, J = 7.6 Hz, 1H), 5.15 (m, 1H),
4.67 (ddd, J = 2.4, 10.0, 12.2 Hz, 1H), 4.27-4.09 (m, 3H), 3.83 (s, 1H), 3.74 (dd, J = 8.4, 8.4
Hz, 1H), 3.43 (dd, J = 8.2, 17.8 Hz, 1H), 3.28 (s, 1H), 3.24-3.17 (m, 4H), 3.21 (s, 3H), 3.20
(s, 3H), 3.02 (s, 3H), 2.73 (dd, J = 8.8, 12.4 Hz, 1H), 2.64-2.58 (m, 3H), 2.24-2.16 (m, 1H),
2.11 (s, 3H), 2.02 (s, 3H), 1.86 (dd, J = 12.6, 25.0 Hz, 1H), 1.70 (s, 3H), 1.49 (s, 3H), 0.82
(s, 3H), 0.64 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 210.0, 202.7, 174.8, 174.4, 170.3,
170.0, 144.5, 144.4, 136.4, 135.0, 129.1, 128.9, 124.1, 122.8, 122.2, 120.3, 107.4, 107.3,
80.3, 72.1, 71.6, 70.7, 69.6, 63.5, 61.5, 56.9, 54.9, 52.1, 49.0, 43.9, 40.0, 38.2, 38.1, 31.0,
30.2, 29.9, 26.4, 26.2, 24.6, 21.3, 21.0, 21.0, 19.4; HRMS (EI) m/z 398.1840 [calc’d for
C22H26N2O5 (M+) 398.1842]. 23c: (171 mg, 11% yield). FTIR (thin film/NaCl) 2967, 2882,
1738, 1713, 1603, 1462, 1370, 1340, 1308, 1233, 1054, 917, 787, 732 cm−1; 1H NMR (500
MHz, CDCl3) δ 7.36 (t, J = 8.0 Hz, 1H), 7.21 (d, J = 8.1 Hz, 1H), 6.76 (d, J = 7.6 Hz, 1H),
5.23 (t, J = 4.7 Hz, 1H), 4.10 (t, J = 8.1 Hz, 1H), 3.69 (t, J = 9.1 Hz, 1H), 3.52 (ddd, J = 5.1,
8.0, 9.3 Hz, 1H), 3.34 (s, 1H), 3.18 (s, 3H), 2.71 (dd, J = 8.0, 12.1 Hz, 1H), 2.58 (s, 3H),
2.31 (ddd, J = 5.3, 8.2, 13.8 Hz, 1H), 2.07 (s, 3H), 1.81 (dd, J = 13.2, 13.2 Hz, 1H), 1.72 (s,
3H), 0.80 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 209.6, 174.5, 170.2, 144.5, 135.8, 128.7,
123.9, 122.0, 107.1, 74.6, 66.5, 66.4, 63.8, 53.7, 52.5, 39.1, 36.9, 30.4, 29.7, 26.1, 20.8,
19.3; HRMS (EI) m/z 398.1851 [calc’d for C22H26N2O5 (M+) 398.1842].
4.1.7. Diketone 26—To a solution of diazo ketone 4 (115 mg, 0.43 mmol, 1.0 equiv.) and
allylic alcohol 24 (66 mg, 0.43 mmol, 1.0 equiv.) in CH2Cl2 (5 mL) was added Rh2(OAc)4
(1.9 mg, 0.004 mmol, 0.01 equiv.). Gas evolution was observed and the reaction turned dark
brown. After stirring at rt for 30 minutes, the mixture was concentrated to afford a dark
brown oil which was subsequently dissolved in xylenes (8 mL) and heated at reflux for 20
minutes. After cooling to room temperature, the reaction was concentrated and purified by
silica gel column chromatography (30% hexane/EtOAc) to afford diketone 26 as yellow
crystals (103 mg, 60% yield). m.p. 137–139 °C; FTIR (thin film/NaCl) 2966, 2900, 1705,
1599, 1469, 1411, 1370, 1338, 1295, 1268, 1251, 1082, 1022 cm−1; 1H NMR (500 MHz,
CDCl3) δ 7.71 (d, J = 7.8 Hz, 1H), 7.52 (t, J = 7.8 Hz, 1H), 7.13 (d, J = 7.7 Hz, 1H), 5.36 (s,
1H), 5.28 (s, 1H), 3.39 (s, 1H), 3.32 (dd, J = 2.2, 11.0 Hz, 1H), 3.27 (s, 3H), 2.87 (dd, J =
11.2, 13.8 Hz, 1H), 2.27 (d, J = 14.1 Hz, 1H), 1.50 (s, 3H), 0.95 (s, 3H), 0.07 (s, 9H); 13C
NMR (125 MHz, CDCl3) δ 203.7, 191.7, 174.4, 145.0, 129.6, 129.4, 128.3, 128.2, 124.4,
120.8, 113.1, 104.1, 96.4, 56.0, 53.0, 38.4, 33.2, 26.4, 22.4, 20.9, −0.3; HRMS (EI) m/z
393.1756 [calc’d for C23H27NO3Si (M+) 393.1760].
4.1.8. Isoxazolidine 28—To a solution of diketone 26 (118 mg, 0.30 mmol, 1.0 equiv.) in
MeOH (6 mL) was added N -methylhydroxylamine hydrochloride (126 mg, 1.50 mmol, 5.0
equiv.) followed by pyridine (171 μL, 2.10 mmol, 7.0 equiv.). The reaction mixture was
heated at reflux for 15 hours and was concentrated after cooling to room temperature. The
residual pyridine was removed in vacuo and the crude white solid was redissolved in EtOH
(12 mL) and imidazole hydrochloride was added (63 mg, 0.60 mmol, 2.0 equiv.). The
mixture was heated at reflux for an additional 14 hours. After cooling to room temperature,
the reaction was concentrated and purified by silica gel column chromatography (25%
EtOAc/hexane) to furnish cycloadduct 28 as white crystals (89 mg, 70% yield). m.p. 210–
211 °C; FTIR (thin film/NaCl) 2967, 2928, 2873, 2172, 1736, 1708, 1606, 1589, 1467,
1386, 1338, 1299, 1250, 1214, 1172, 1106, 1084 cm−1; 1H NMR (500 MHz, CDCl3) δ 7.30
(t, J = 7.8 Hz, 1H), 6.95 (d, J = 8.0 Hz, 1H), 6.72 (d, J = 7.6 Hz, 1H), 4.09 (d, J = 8.3 Hz,
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1H), 4.00 (d, J = 8.2 Hz, 1H), 3.96 (s, 1H), 3.28 (s, 3H), 3.16 (s, 3H), 2.71 (d, J = 14.4 Hz,
1H), 2.46-2.38 (m, 2H), 1.56 (s, 3H), 0.81 (s, 3H), −0.25 (s, 9H); 13C NMR (125 MHz,
CDCl3) δ 213.1, 175.0, 144.2, 132.1, 128.6, 125.0, 118.6, 107.2, 107.1, 90.7, 81.8, 64.4,
54.2, 52.8, 41.0, 39.3, 37.4, 26.1, 25.1, 21.8, 0.0; HRMS (EI) m/z 422.2018 [calc’d for
C24H30N2O3Si (M+) 422.2026].
4.1.9. Diketone 30—Diketone 15 (187 mg, 0.63, 1.0 equiv.) and olefin 29 (882 mg, 4.40
mmol, 7.0 equiv.) were diluted in CH2Cl2 (15.7 mL) and stirred for 10 minutes. Grubbs 2nd
generation catalyst (54 mg, 0.063 mmol, 0.1 equiv.) was then added and the reaction was
stirred at reflux overnight (approx. 12 hours). Upon completion as indicated by TLC, the
reaction was concentrated and immediately purified via column chromatography (20%
EtOAc/hexanes) to give the resulting coupled adduct (193 mg, 0.411 mmol). The coupled
adduct was taken up in MeOH (41 mL) before pyridinium p-toluenesulfonate (21 mg, 0.082
mmol, 0.2 equiv.) was added. The reaction was stirred at room temperature over 12 hours
whereupon TLC indicated the consumption of starting material. The reaction was
concentrated, re-dissolved in EtOAc, washed with sat. NaHCO3, brine, and dried over
Na2SO4. Purification of the concentrated mixture by flash chromatography (50% EtOAc/
hexanes) gave diketone product 30 (104 mg, E/Z: 2:1, 47% yield, 2 steps) as a yellow oil.
FTIR (thin film/NaCl) 3420, 2935, 1715, 1604, 1473, 1372, 1339, 1300, 1272 cm−1; 1H
NMR (400 MHz, CDCl3) δ 7.70 (d, J = 8.0 Hz, 1H), 7.69 (d, J = 8.0 Hz, 1H), 7.49 (t, J = 8.0
Hz, 2H), 7.29 (d, J = 7.6 Hz, 2H), 5.04-4.98 (m, 2H), 3.68-3.57 (m, 4H), 3.37 (s, 1H), 3.36
(s, 1H), 3.24 (s, 6H), 2.90-2.86 (m, 2H), 2.82-2.74 (m, 2H), 2.37-2.25 (m, 2H), 2.22-2.05
(m, 6H), 1.64 (s, 6H), 1.52 (s, 3H), 1.5 (s, 3H), 0.93 (s, 6H); 13C NMR (100 MHz, CDCl3) δ
205.9, 193.6, 174.5, 145.3, 135.2, 129.7, 129.0, 128.9, 124.2, 123.9, 120.92, 120.87, 113.5,
113.4, 60.6, 60.2, 58.3, 58.2, 53.4, 53.2, 43.0, 38.6, 38.3, 35.1, 26.6, 24.6, 24.5, 23.4, 23.0,
22.9, 21.3, 21.2, 15.9; HRMS (EI) m/z 356.1862 [calc’d for C21H26NO4 (M+) 356.1856].
4.1.10. Selenide 31—A solution of alcohol 30 (60 mg, 0.17 mmol, 1.0 equiv.) in THF
(1.69 mL) was treated with o-nitrophenylselenocyanate (46 mg, 0.20 mmol, 1.2 equiv.) at
room temperature. The mixture was stirred for 10 minutes before tri-n-butylphosphine (50.5
μL, 0.20, 1.2 equiv.) was added. Upon completion as indicated by TLC (approx. 2 hours) an
aliquot of sat. NH4Cl was added. The resulting brown mixture was extracted with Et2O,
washed with brine, dried over MgSO4, and concentrated in vacuo. Purification of the
concentrated mixture by flash chromatography (30% EtOAc/hexanes) gave selenide 31 (49
mg, 54% yield) as a yellow oil. The major diastereomer was characterized as follows: FTIR
(thin film/NaCl) 2970, 2930, 1716, 1604, 1513, 1473, 1332, 1303, 1271 cm−1; 1H NMR
(400 MHz, CDCl3) δ 8.30 (d, J = 8.4 Hz, 1H), 7.71 (d, J = 8.0 Hz, 1H), 7.58-7.49 (m, 3H),
7.31 (t, J = 8.0 Hz, 1H), 7.13 (d, J = 7.6 Hz, 1H), 5.02 (t, J = 7.2 Hz, 1H), 3.39 (s, 1H), 3.26
(s, 3H), 2.99-2.88 (m, 3H), 2.81 (ddd, J = 8.0, 13.2, 13.2 Hz, 1H), 2.39-2.35 (m, 2H), 2.15
(dd, J = 6.0, 13.6 Hz, 1H), 1.70 (s, 3H), 1.53 (s, 3H), 0.96 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 205.6, 192.8, 174.5, 147.0, 145.2, 136.9, 133.8, 129.8, 129.3, 128.8, 126.6, 125.4,
122.9, 120.9, 113.4, 58.1, 53.3, 38.6, 38.2, 26.6, 24.6, 23.0, 21.2, 16.0; HRMS (EI) m/z
563.1060 [calc’d for C27H28N2NaO5Se (M+) 563.1056].
4.1.11. Vinyl epoxide 32—In a flask open to air, selenide 31 (49 mg, 0.09, 1.0 equiv.)
was diluted with CH2Cl2 (7 mL) and cooled to −78 °C. Freshly made dimethyldioxirane in
acetone (7 mL, approx. 0.07–0.09 M) was added rapidly. The solution was stirred at −78 °C
for 30 minutes and then gradually warmed to room temperature. The reaction was then
concentrated in vacuo and subsequently purified by flash chromatography (20% EtOAc/
hexanes eluent) to give diastereomeric vinyl epoxide 32 (23 mg, 72% yield) as a pale yellow
solid. The mixture of diastereomers were characterized as follows: FTIR (thin film/NaCl)
2970, 1716, 1604, 1473, 1373, 1339, 1300, 1272 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.72
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(d, J = 8.0 Hz, 2H), 7.52 (t, J = 8.0 Hz, 2H), 7.13 (d, J = 8.0 Hz, 2H), 5.82 (dd, J = 11.2,
17.6 Hz, 1H), 5.61 (dd, J = 10.8, 17.6 Hz, 1H), 5.29 (d, J = 17.2 Hz, 2H), 5.17 (d, J = 10.8
Hz, 2H), 3.39 (s, 1H), 3.38 (s, 1H), 3.25 (s, 6H), 3.14-3.10 (m, 2H), 2.70 (dd, J = 3.6, 8.4
Hz, 1H), 2.59 (dd, J = 4.0, 7.6 Hz, 1H), 2.47 (ddd, J = 4.0, 11.6, 13.6 Hz, 1H), 2.36 (ddd, J =
3.6, 11.6, 14.0 Hz, 1H), 1.59-1.53 (m, 2H), 1.49 (s, 3H), 1.45 (s, 3H), 1.37 (s, 3H), 1.36 (s,
3H), 0.93 (s, 3H), 0.88 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 204.7, 192.1, 174.5, 145.2,
140.0, 135.5, 129.9, 129.3, 128.7, 121.1, 118.0, 116.5, 113.5, 63.4, 63.1, 62.1, 60.8, 54.7,
53.1, 38.8, 26.6, 25.4, 24.9, 22.8, 21.8, 21.1, 15.3; HRMS (EI) m/z 376.1526 [calc’d for
C21H23NNaO4 (M+) 376.1519].
4.1.12. Hemiacetals 33—Triphenylphosphine (20.0 mg, 75.0 μmol, 0.5 equiv.) and
tris(dibenzylideneacetone)-dipalladium(0)-chloroform (7.0 mg, 7.5 μmol, 0.05 equiv) were
combined and diluted with toluene (0.8 mL). The deep purple mixture changed to a deep
yellow after 1 hour. 1,1,1,3,3,3-Hexafluoro-2-phenyl-2-propanol (25.3 μL, 0.15 mmol, 1.0
equiv.) was then added. After 10 minutes the mixture turned a deep red-orange and was
added via cannula into a vial containing vinyl epoxide 32 (53.0 mg, 0.15 mmol, 1.0 equiv.)
The reaction was then submerged in a 35 °C oil bath and left overnight (approx. 12 hours) to
react. After completion as indicated by TLC, the reaction was rapidly concentrated and
immediately purified by flash chromatography (20% EtOAc/hexanes) to give diastereomeric
acetals 33 (31 mg, 58% yield) as an off white solid. The mixture of diastereomers was
characterized as follows: FTIR (thin film/NaCl) 3377, 2926, 1699, 1604, 1372, 1339, 1298,
1216 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.64 (d, J = 8.0 Hz, 2H), 7.43 (t, J = 8.0 Hz, 2H),
7.04 (d, J = 8.0 Hz, 2H), 6.46 (dd, J = 11.2, 18.0 Hz, 1H), 6.34 (dd, J = 11.6, 18.4 Hz, 1H),
5.45 (s, 1H), 5.3-5.02 (m, 8H), 4.72 (m, 1H), 4.14 (s, 1H), 4.08 (s, 1H), 3.24 (s, 3H), 3.23 (s,
3H), 3.03 (d, J = 11.6 Hz, 2H), 2.78 (m, 1H), 2.33-2.15 (m, 4H), 1.96-1.91 (m, 1H), 1.67 (s,
3H), 1.63 (s, 3H), 0.85 (s, 3H), 0.77 (s, 3H);13C NMR (100 MHz, CDCl3) δ 196.6, 196.5,
175.9, 146.1, 145.9, 144.8, 136.5, 136.1, 131.3, 131.1, 129.0, 128.9, 127.9, 127.8, 122.2,
121.9, 114.7, 114.4, 114.2, 112.2, 112.1, 103.2, 102.6, 78.0, 75.9, 53.6, 52.7, 52.6, 50.5,
35.4, 35.2, 33.3, 31.1, 26.4, 25.3, 25.2, 23.8, 23.7; HRMS (EI) m/z 376.1519 [calc’d for
C21H23NNaO4 (M+) 376.1519].
4.1.13. Aminal 39—A 500 mL flask equipped with an addition funnel (containing 30 g 4
Å molecular sieves) and connected to a reflux condenser was charged with p-TSA (85 mg,
0.44 mmol, 1.0 equiv.) and benzene (150 mL). The resulting suspension was then heated at
reflux for 1 hour before isoxazolidine 23 (175 mg, 0.44 mmol, 1.0 equiv.) was introduced as
a solid in one portion. The resulting suspension was immersed into an oil bath and heated at
110 °C for 48 hours to provide a dark brown reaction mixture containing a small amount of
a brown precipitate. The reaction was cooled to 0 °C and treated with Et3N (61 μL, 0.44
mmol, 1.0 equiv.). Concentration provided a brown foam that was purified by silica gel
chromatography (50–100% EtOAc/hexanes) to afford recovered starting material 23 (11 mg,
11%) and aminal 39 (94 mg, 54% yield, 65% BORSM) as a white solid. m.p. 251–254 °C;
FTIR (thin film/NaCl) 2967, 1711, 1606, 1457, 1237 cm−1; 1H NMR (500 MHz, CDCl3) δ
7.49 (t, J = 8.1 Hz, 1H), 7.32 (d, J = 8.1 Hz, 1H), 6.83 (d, J = 7.7 Hz, 1H), 4.60 (d, J = 10.7
Hz, 1H), 4.52 (d, J = 10.3 Hz, 1H), 4.34 (ddd, J = 5.0, 6.9, 12.5 Hz, 1H), 4.17 (dd, J = 5.5,
11.9 Hz, 1H), 3.35 (t, J = 12.1 Hz, 1H), 3.32 (s, 1H), 3.19 (s, 3H), 3.12-3.07 (m, 1H), 2.52
(dd, J = 7.6, 12.6 Hz, 1H), 2.16 (bs, 1H), 2.00 (s, 3H), 1.89-1.75 (m, 2H), 1.67 (s, 3H), 0.79
(s, 3H); 13C NMR (100 MHz, CDCl3) δ 211.1, 174.5, 170.3, 144.7, 139.6, 130.2, 123.6,
119.2, 107.8, 77.4, 69.9, 68.1, 66.1, 54.9, 51.3, 45.3, 39.2, 29.7, 28.8, 26.2, 21.1, 19.8;
HRMS (EI) m/z 398.1839 [calc’d for C22H26N2O5 (M+) 398.1842].
4.1.14. Amino alcohol 40—A solution of aminal 39 (610 mg, 1.53 mmol, 1.0 equiv.) in
MeOH (100 mL) was treated with hydroxylamine hydrochloride (1.06 g, 15.33 mmol, 10.0
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equiv.). The solution that resulted was heated at reflux for 30 minutes before being cooled,
concentrated, taken up in EtOAc (200 mL) and quenched with saturated NaHCO3 (250 mL).
Separation of the layers and extraction of the aqueous layer with EtOAc was followed by
washing with brine, drying over Na2SO4, and concentration under reduced pressure. The
resulting residue was purified using silica gel chromatography (30–100% EtOAc/hexanes)
to furnish amino alcohol 40 (577 mg, 98% yield) as a white solid. m.p. dec. >205 °C; FTIR
(thin film/NaCl) 3260, 2968, 1715, 1608, 1465, 1240, 1019 cm−1; 1H NMR (400 MHz,
CDCl3) δ 7.47 (t, J = 7.8 Hz, 1H), 7.34 (d, J = 8.0 Hz, 1H), 6.79 (d, J = 7.6 Hz, 1H),
4.32-4.27 (m, 1H), 3.58-3.47 (m, 2H), 3.18 (s, 3H), 3.16 (s, 2H), 2.63 (dd, J = 7.4, 12.0 Hz,
1H), 2.00 (s, 3H), 1.92-1.78 (m, 2H), 1.65 (s, 3H), 0.82 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 212.0, 174.2, 170.4, 144.3, 141.1, 130.2, 121.7, 120.8, 107.4, 68.8, 67.2, 62.1,
54.9, 54.6, 51.3, 38.6, 29.3, 29.2, 26.1, 21.0, 19.6; HRMS (EI) m/z 386.1834 [calc’d for
C21H26N2O5 (M+) 386.1842].
4.1.15. Alcohol 41—A solution of amino alcohol 40 (53 mg, 0.14 mmol, 1.0 equiv.) in
THF (3.4 mL) at 0 °C was treated with freshly prepared acetic formic anhydride [0.52 mL,
prepared by heating equal amounts of acetic anhydride (0.26 mL) and formic acid (0.26 mL)
at 60 °C for 1 hour]. Stirring was continued for 5 minutes at this temperature and then at
room temperature for 30 minutes. The reaction was then concentrated under reduced
pressure. The crude mixture was then diluted in MeOH (3.4 mL) at room temperature and
was treated with Et3N (0.19 mL, 1.37 mmol, 10.0 equiv.). The solution was allowed to stir
for 10 minutes, at which point TLC indicated complete consumption of starting material.
Concentration in vacuo and purification by flash chromatography (100% EtOAc) furnished
alcohol 41 (52 mg, 91% yield) as a pale yellow foam. m.p. 181–184 °C; FTIR (thin film/
NaCl) 3300, 1730, 1694, 1609, 1466, 1236 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.07 (m,
2H), 7.49 (d, J = 7.8 Hz, 1H), 7.41 (t, J = 8.0 Hz, 1H), 6.79 (d, J = 7.2 Hz, 1H), 4.62 (ddd, J
= 5.5, 7.6, 12.5 Hz, 1H), 3.79-3.71 (m, 2H), 3.65 (s, 1H), 3.42 (dt, J = 3.0, 7.3 Hz, 1H), 3.18
(s, 3H), 2.60 (dd, J = 7.9, 12.1 Hz, 1H), 2.49 (t, J = 3.7 Hz, 1H), 2.01 (s, 3H), 1.90-1.78 (m,
2H), 1.67 (s, 3H), 0.83 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 206.8, 175.1, 170.3, 160.2,
143.4, 138.0, 129.1, 124.9, 121.1, 107.3, 68.8, 68.6, 61.7, 55.1, 51.8, 51.7, 38.4, 29.2, 28.8,
26.1, 21.0, 20.0; HRMS (EI) m/z 414.1782 [calc’d for C22H26N2O6 (M+) 414.1791].
4.1.16. Alcohol 42—A solution of alcohol 41 (207 mg, 0.5 mmol, 1.0 equiv.) in CH2Cl2
(10 mL) was treated with Dess-Martin periodinane (319 mg, 0.75 mmol, 1.5 equiv.) and
stirred at room temperature for 30 minutes, at which point TLC indicated the reaction
complete. The reaction was cooled to 0 °C before saturated NaHSO3 (5 mL) and saturated
NaHCO3 (5 mL) were added. The two layers were separated and the organic extract was
washed with brine, dried over Na2SO4, filtered and concentrated. The crude reaction
mixture was diluted in CH2Cl2 (10 mL) and stirred at 0 °C before triethylamine (77 μL, 0.55
mmol, 1.1 equiv.) was added. After 30 minutes acetic acid (31 μL, 0.55 mmol, 1.1 equiv.)
was added and the reaction was partitioned between CH2Cl2 (20 mL) and saturated
NaHCO3 (20 mL). The organic layer was washed with brine, dried over Na2SO4, filtered
and concentrated. The crude reaction mixture, diluted in THF (10 mL) was cooled to 0 °C. A
3.0 M solution of methyl magnesium bromide in Et2O (0.37 mL, 1.11 mmol, 3.0 equiv.) was
added and the reaction was stirred for 30 minutes. Upon consumption of starting material,
the reaction was quenched with 1 M NH4Cl, extracted with EtOAc, washed with brine, and
dried over Na2SO4. The resulting mixture was purified by flash chromatography (90%
EtOAc/hexanes) to give secondary alcohol 42 as a mixture of diastereomers (134 mg, 73%
yield, 3 steps). The complex mixture was carried through the next step and characterized.
4.1.17. Enone 43—A solution of alcohol 42 (20 mg, 0.05 mmol, 1.0 equiv.) in CH2Cl2
(1.9 mL) was treated with Dess-Martin periodinane (73 mg, 0.17 mmol, 3.0 equiv.) and
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stirred at room temperature for 8 hours, at which point TLC indicated the reaction complete.
The reaction was cooled to 0 °C before saturated NaHSO3 (2 mL) and saturated NaHCO3 (2
mL) were added. The two layers were separated and the organic extract was washed with
brine, dried over Na2SO4, filtered and concentrated. Purification by flash chromatography
(75% EtOAc/hexanes) gave enone 43 (7 mg, 35% yield) as a pale yellow oil. FTIR (thin
film/NaCl) 3329, 3055, 2970, 2917, 1731, 1698, 1609, 1465, 1368, 1340, 1266, 1243
cm−1; 1H NMR (400 MHz, CDCl3) δ 8.14 (d, J = 1.2 Hz, 1H), 7.25 (t, J = 8.0 Hz, 1H),
7.04-7.02 (m, 1H), 6.9 (s, 1H), 6.70 (d, J = 8.0 Hz, 1H), 3.88 (s, 1H), 3.15 (s, 3H), 2.58-2.49
(m, 2H), 2.45 (s, 3H), 2.36-2.28 (m, 1H), 1.68 (s, 3H), 0.94 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 201.1, 174.9, 160.1, 142.8, 134.6, 129.5, 126.0, 120.9, 107.2, 69.9, 51.8, 51.7,
37.7, 29.2, 27.8, 27.4, 26.3, 20.6; HRMS (EI) m/z 389.1480 [cacl’d for C21H22N2NaO4 (M
+) 389.1472].
4.1.18. Allylic Alcohol 38—A solution of enone 43 (66 mg, 0.18 mmol, 1.0 equiv.) in
THF (8 mL) was cooled to 0 °C. A 3.0 M solution of methyl magnesium bromide in Et2O
(0.30 mL, 0.90 mmol, 5.0 equiv.) was added and the reaction was stirred for 7 hours. Upon
consumption of starting material, the reaction was quenched with 1 M NH4Cl, extracted
with EtOAc, washed with brine, and dried over Na2SO4. The resulting mixture was purified
by flash chromatography (2% MeOH/CHCl3) to give allylic alcohol 38 (26 mg, 26% yield)
as a yellow oil.1H NMR (400 MHz, DMSO-d6) δ 9.42 (s, 1H), 8.02 (s, 1H), 7.27 (t, J = 8.0
Hz, 1H), 7.18 (d, J = 8.0 Hz, 1H), 6.85 (d, J = 7.6 Hz, 1H), 6.06 (s, 1H), 5.81-5.79 (m, 1H),
3.80 (s, 1H), 3.10 (s, 3H), 2.31-2.18 (m, 2H), 1.79-1.73 (m, 1H), 1.55 (s, 3H), 1.47 (s, 3H),
1.35 (s, 3H), 0.76 (s, 3H); 13C NMR (100 MHz, DMSO-d6) δ 201.7, 174.5, 160.1, 147.3,
141.5, 136.4, 128.6, 125.3, 124.4, 121.1, 106.5, 73.0, 70.9, 51.3, 51.2, 36.5, 31.4, 30.2, 28.5,
25.8, 25.2, 19.8; HRMS (EI) m/z 405.1789 [calc’d for C22H26N2NaO4 (M+) 405.1785].
4.1.19. Chlorinated Product 44—Tertiary allylic alcohol 38 (51 mg, 0.133 mmol, 1.0
equiv.) was diluted in CH3CN (10 mL) and stirred at 0 °C. Cerium(III) chloride
heptahydrate (149 mg, 0.40 mmol, 3.0 equiv.) was added followed by addition of a 0.1 M
aqueous solution of sodium hypochlorite (10.7 mL, 1.07 mmol, 8.0 equiv.). The reaction
was stirred from 0 °C to room temperature over 9 hours whereupon TLC indicated
consumption of starting material. The reaction was cooled to 0 °C before saturated sodium
sulfite (10 mL) was added and stirred for 10 minutes. Chloroform was added and the layers
were separated. The aqueous layer was extracted twice more with chloroform and the
organic partitions were combine, washed with brine, and dried over Na2SO4. Purification of
the filtrate by flash chromatography (33% EtOAc/hexanes) furnished chlorinated product 44
(49 mg, 71% yield) as a colorless foam. 1H NMR (400 MHz, CDCl3) δ 8.05 (s, 1H) 7.41 (s,
1H), 5.03-4.98 (dd, J = 9.2, 11.6 Hz, 1H), 3.54 (s, 3H), 3.02 (s, 1H), 2.63-2.57 (dd, J = 9.6,
10.4 Hz, 1H), 2.53-2.45 (ddd, J = 8.8, 10.8, 14.0 Hz, 1H), 2.27 (s, 3H), 2.0 (s, 3H),
1.85-1.76 (ddd, J = 9.2, 11.4, 14.0 1H), 1.71 (s, 3H), 0.80 (s, 3H); 13C NMR (125 MHz,
CDCl3) δ 206.5, 175.7, 171.7, 160.0, 140.3, 132.7, 132.6, 128.2, 127.4, 117.3, 90.3, 75.8,
60.8, 58.0, 54.4, 52.4, 40.6, 34.0, 30.1, 29.9, 26.8, 26.4, 26.0, 22.0, 21.4, 14.6, 14.5; HRMS
(EI) m/z 541.0233 [calc’d for C22H22Cl4N2NaO4 (M+) 541.0226].
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Scheme 1.
Retrosynthetic analysis
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